Cartesian Therapeutics, Inc (RNAC) insider trading
Every open-market stock purchase and sale by Cartesian Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $206K over the last 12 months (1 buy).
- Insiders sold $259K over the last 12 months (3 sales).
- Last insider buy: Timothy C Barabe (Director), $206K, 10 months ago.
Last 12 months: insiders bought $206K (1 buy) and sold $259K (3 sales). Last close $5.86 on Jun 7, 2026.
Recent RNAC insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 2, 2026 | Elizabeth Hoge (10% owner) | Bought (not open market) | — |
| Apr 2, 2026 | Elizabeth Hoge (10% owner) | Bought (not open market) | — |
| Apr 2, 2026 | Murat Kalayoglu (10% owner) | Bought (not open market) | — |
| Apr 2, 2026 | Murat Kalayoglu (10% owner) | Bought (not open market) | — |
| Mar 13, 2026 | Michael Singer (Director) | Sold (not open market) | — |
| Jan 6, 2026 | Carsten Brunn (CEO) | Sold | $162K |
| Jan 6, 2026 | Blaine Davis (CFO) | Sold | $72.2K |
| Jan 6, 2026 | Milos Miljkovic (C-suite exec) | Sold | $24.4K |
| Jan 2, 2026 | Michael Singer (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Patrick J Zenner (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Kemal Malik (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Timothy C Barabe (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Timothy C Barabe (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Carsten Brunn (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Patrick J Zenner (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Blaine Davis (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Blaine Davis (CFO) | Bought (not open market) | — |
| Jan 2, 2026 | Carsten Brunn (CEO) | Bought (not open market) | — |
| Jan 2, 2026 | Timothy A Springer (10% owner) | Bought (not open market) | — |
| Jan 2, 2026 | June Ann Seymour (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | June Ann Seymour (C-suite exec) | Bought (not open market) | — |
| Jan 2, 2026 | Michael Singer (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Nishan M DeSilva (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Nishan M DeSilva (Director) | Bought (not open market) | — |
| Jan 2, 2026 | Emily English (C-suite exec) | Bought (not open market) | — |
Who's trading RNAC
- Elizabeth Hoge, 10% owner: other filings, last Apr 2, 2026
- Murat Kalayoglu, 10% owner: other filings, last Apr 2, 2026
- Michael Singer, Director: other filings, last Mar 13, 2026
- Carsten Brunn, CEO: sold $162K (1 sale), last Jan 6, 2026
- Milos Miljkovic, C-suite exec: sold $24.4K (1 sale), last Jan 6, 2026
- Blaine Davis, CFO: sold $72.2K (1 sale), last Jan 6, 2026
- Patrick J Zenner, Director: other filings, last Jan 2, 2026
- Nishan M DeSilva, Director: other filings, last Jan 2, 2026
- Emily English, C-suite exec: other filings, last Jan 2, 2026
- Kemal Malik, Director: other filings, last Jan 2, 2026
- Timothy A Springer, 10% owner: other filings, last Jan 2, 2026
- June Ann Seymour, C-suite exec: other filings, last Jan 2, 2026
- Timothy C Barabe, Director: bought $206K (1 buy), last Jan 2, 2026
- Adrian Ion Bot, Director: other filings, last Dec 16, 2025
Get free alerts when an insider at Cartesian Therapeutics, Inc files a new trade →